Stockreport

Aeglea BioTherapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Aeglea BioTherapeutics, Inc.  (AGLE) 
Last aeglea biotherapeutics, inc. earnings: 8/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aegleabio.com/investor-overview
PDF AUSTIN, Texas, April 30, 2020 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (Nasdaq:AGLE), a clinical-stage biotechnology company developing next-generation human e [Read more]